---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-089524"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2026-08-03T12:34:24+00:00"
generated_at: "2026-08-03T12:35:13.278440+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "low"
source: SEC EDGAR
---

# Supernus and Indivior file investor presentation for proposed merger of equals; terms undisclosed

## Summary
- Conference call held August 3, 2026 at 8:30 a.m. ET to discuss merger of equals.
- Merger of equals aims to create a diversified CNS biopharmaceutical leader with significant scale.
- Forward-looking statements reference a special dividend funded by additional indebtedness; amount not specified.
- Indivior to file Form S-4 with joint proxy statement/prospectus for stockholder vote.
- Investor presentation filed with SEC on August 3, 2026.

## SEC filing metadata
- accession: 0001104659-26-089524
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2026-08-03T12:34:24+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000110465926089524/0001104659-26-089524-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000110465926089524/tm2622009d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-089524
- JSON: https://secwatch.observer/filing/0001104659-26-089524.json
- Plain text: https://secwatch.observer/filing/0001104659-26-089524.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.